Gastroprotective effects of amtolmetin guacyl: A new non-steroidal anti-inflammatory drug that activates inducible gastri nitric oxide synthase

Digestive and Liver Disease

Volumn 34, Issue 6, 2002, Pages 403-410

  Coruzzi, G ^a   Coppelli, G ^a   Spaggiari, S ^a   Cavestro, G M ^a   Okolicsanyi, L ^a   Lo Giudice, P ^b   Pisano, C ^b   Tepperman, B L ^c  

^a UNIVERSITY OF PARMA   (Italy)

^b Sigma Tau SpA   (Italy)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Amtolmetin guacyl; Gastroprotection; Nitric oxide; Non steroidal anti inflammatory drug

Indexed keywords

ALCOHOL; AMTOLMETIN GUACIL; BACTERIUM LIPOPOLYSACCHARIDE; ISOENZYME; MYELOPEROXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN; TOLMETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ESCHERICHIA COLI; NONHUMAN; PROTEIN ANALYSIS; RAT; STOMACH INJURY; STOMACH MUCOSA BLOOD FLOW; STOMACH PROTECTION; TISSUE HOMOGENATE; ULCER; WESTERN BLOTTING;

EID: 0036080302     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)80037-8     Document Type: Article

References (51)

1. Profile of activity of a new anti-inflammatory agent, ST 679 (MED 15)
2. Studies on the gastric tolerability of the new non-steroidal anti-inflammatory drug amtolmetin guacyl
3. Gastrosparing effect of new antiinflammatory drug amtolmetin guacyl in the rat. Involvement of nitric oxide
4. Clinical study of the therapeutic activity and tolerability of Artromed in comparison with piroxicam in rheumatoid arthritic patients
5. A clinical study on the anti-inflammatory activity and gastrointestinal tolerability of amtolmetin guacyl, a new NSAID, compared with diclofenac in elderly patients with osteoarticular diseases
6. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis
7. The mechanism of action of amtolmetin guacyl, a new gastroprotective nonsteroidal anti-inflammatory drug
8. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa
9. Role of oxygen-derived metabolites in the rat gastric mucosal injury induced by nitric oxide donors
10. Actions of isoform-selective and non-selective nitric oxide synthase inhibitors on endotoxin-induced vascular leakage in rat colon
11. Involvement of nitric oxide and prostaglandins in gastroprotection induced by bacterial lipopolysaccharide
12. Nitric oxide synthase induction and cytoprotection of rat gastric mucosa from injury by ethanol
13. Effects of endotoxin on gastric injury from luminal irritants in rats: Potential roles of nitric oxide
14. iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion
15. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo
16. Endotoxin protects the gastric mucosa against ulcerogenic stimuli
17. Aspirin-induced acute gastric mucosal injury is a neutrophil-dependent process in rats
18. Mechanism of non-steroidal anti-inflammatory drug-gastropathy
19. Gastric ulceration induced by non-steroidal antiinflammatory drugs is a neutrophil-dependent process
20. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: Integrity in the balance
21. Nitric oxide: An endogenous modulator of leukocyte adhesion
22. Nitric oxide: Physiology, pathophysiology and pharmacology
23. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: Assessment of inflammation in rat and hamster models
24. High-performance liquid chromatographic evaluation of MED 15 and its metabolites MED 5 and tolmetin in rat plasma
25. Stimulation of afferent nerve endings by intragastric capsaicin protects against ethanol-induced damage of gastric mucosa
26. Effect of nitric oxide on integrity, blood flow and cGMP levels in the rat gastric mucosa: Modulation by sialoadenectomy
27. Regulation of gastric mucosal integrity by endogenous nitric oxide: Interaction with prostanoids and sensory neuropeptides in the rat
28. Nitric oxide donors increase mucus gel thickness in rat stomach
29. Nitric oxide: A regulator of mucosal defence and injury
30. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach
31. Nitric oxide-releasing NSAIDs: A novel approach for reducing gastropathy
32. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs
33. Nitric oxide synthase induction and intestinal epithelial cell viability in rats
34. Lipopolysaccharide induces calcium-independent nitric oxide synthase activity and affects cellular viability in rat gastric mucosal cells
35. Activation of apoptotic caspase-3 and nitric oxide synthase-2 in gastric mucosal injury induced by indomethacin
36. Does upregulation of inducible nitric oxide synthase (iNOS) render the stomach more susceptible to damage?
37. Inhibition of inducible nitric oxide synthase delays gastric ulcer healing in the rat
38. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers
39. Inducible types of cyclooxygenase and nitric oxide synthase in adaptive cytoprotection in rat stomachs
40. Nitric oxide synthase: Catalytic function and progress towards selective inhibition
41. Gastric mucosal barrier
42. Effect of several drugs on gastric potential difference in man
43. Aspirin-induced ultrastructural changes in human gastric mucosa. Correlation with potential difference
44. Effect of human gastrin infusion on gastric potential difference in man
45. Alterations in blood vessels during gastric injury and protection
46. New insights into the mode of action of antiinflammatory drugs
47. Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: Role of neutrophils
48. Effect of neutropenia on gastric mucosal integrity and mucosal nitric oxide synthesis in the rat
49. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxiemia
50. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation
51. Nitric oxide - A mediator of inflammation or mucosal defence